Post nasal drip treatment
First Claim
1. A method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough, the method comprising:
- advancing a treatment delivery portion of a cryotherapy treatment device into a nostril of the patient;
contacting mucosal tissue of the upper airway with the treatment delivery portion, without piercing the mucosal tissue; and
delivering cryogenic cooling from the treatment delivery portion to cool a target tissue selected from the group consisting of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the target tissue and thus treat at least one of post nasal drip or chronic cough in the patient.
3 Assignments
0 Petitions
Accused Products
Abstract
Systems and methods for treating a patient'"'"'s mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.
-
Citations
28 Claims
-
1. A method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough, the method comprising:
-
advancing a treatment delivery portion of a cryotherapy treatment device into a nostril of the patient; contacting mucosal tissue of the upper airway with the treatment delivery portion, without piercing the mucosal tissue; and delivering cryogenic cooling from the treatment delivery portion to cool a target tissue selected from the group consisting of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the target tissue and thus treat at least one of post nasal drip or chronic cough in the patient. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A device for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough, the device comprising:
-
an elongate shaft having a proximal end and a distal end; a handle at the proximal end of the elongate shaft; and a treatment portion at the distal end of the elongate shaft, the treatment portion comprising a treatment surface, the treatment surface comprising; at least two energy delivery members extending longitudinally along the treatment surface; and a temperature sensing member extending longitudinally along the treatment surface and separating the at least two energy delivery members. - View Dependent Claims (15, 16, 17, 18, 19, 20)
-
-
21. A method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough, the method comprising:
-
advancing a treatment portion of the treatment device into a nostril of the patient to contact a treatment surface of the treatment portion with mucosal tissue of the upper airway, without piercing the mucosal tissue; delivering radiofrequency energy from a first electrode on the treatment surface across a temperature sensing member in the treatment surface to a second electrode on the treatment surface to treat at least one tissue selected from the group consisting of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient; measuring an amount of the radiofrequency energy delivered, using the temperature sensing member; and removing the treatment portion from the upper airway without leaving an implant in the upper airway. - View Dependent Claims (22, 23, 24, 25, 26, 27, 28)
-
Specification